← SynDRA
2-Chloro-3-(4-methylpiperazin-1-yl)quinoxaline
SynDRA canonical compound SYN0443769 — structure-anchored drug synonym record
| Clinical phase | Preclinical |
|---|
| Primary target(s) | HTR3A | HTR3B |
|---|
| Mechanism of action | serotonin receptor antagonist |
|---|
Cross-references
Synonyms
- RefChem:1062750
- DTXCID10591414
- VUF-10166
- VUF10166
- Quinoxaline, 2-chloro-3-(4-methyl-1-piperazinyl)-
- VUF10166;VUF-10166
- MFCD01127814
- 2-Chloro-3-(4-methyl-1-piperazinyl)quinoxaline
- SCHEMBL404203
- orb1300520
- HMS3651F21
- HMS3884N20
- EX-A4554
- BDBM50459886
- EBC-06722
- s2865
- SBB079300
- AKOS016010623
- CCG-267078
- SB19512
- NCGC00379152-02
- AC-32765
- AS-68065
- BV174970
- DB-330026
- HY-100552
- 3-chloro-2-(4-methylpiperazinyl)quinoxaline
- SW219811-1
- T6728
- EN300-110943
- F243736
- BRD-K11046126-001-02-0
- Z994862958
Look up 2-Chloro-3-(4-methylpiperazin-1-yl)quinoxaline in the interactive SynDRA portal →